Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Skyworks Solutions Inc (SWKS) Price & Performance

Roivant Sciences Ltd. Common SharesTrade
Skyworks Solutions IncTrade

Price performance (Past 24H)

Key statistics

Roivant Sciences Ltd. Common Shares vs Skyworks Solutions Inc — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.16 (market cap $24.72B), while Skyworks Solutions Inc trades at $77.51 (market cap $12.15B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2× Skyworks Solutions Inc's market cap, and Skyworks Solutions Inc pays a 4.13% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Skyworks Solutions Inc for 50 Days on average.

ROIVSWKS
Market Cap
$24.72B$12.15B
Volume
6,279,4427,390,810
Sector
HealthTechnology
52-Week High
$41.81$91.45
52-Week Low
$16.04$52.50
Typical Hold Time
0 Days50 Days
Enterprise Value
$20.99B$12.03B
Dividend Yield
—4.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Skyworks Solutions Inc

Skyworks Solutions (SWKS) trades at $77.17, down 7.5% in the last session, with a bearish technical signal. The stock has beaten earnings estimates for the last three quarters, but revenue and net income have declined year-over-year. The pending merger with Qorvo is a key development, with regulatory clearances obtained, targeting $500 million in synergies. Analyst consensus is a Buy with a $78.80 price target, slightly above the current price.

The outlook is mixed: the Qorvo merger offers growth potential and cost savings, but declining profitability and negative cash flow pose risks. Investor sentiment is cautious due to recent price volatility and earnings pressure. Upside depends on merger execution and market recovery, while downside risks include integration challenges and competitive pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ROIV
100% Buy0% Sell
Avg holding period · 0 Days
SWKS
19% Buy81% Sell
Avg holding period · 50 Days

Top news

Latest headlines on both assets

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →

About Skyworks Solutions Inc

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Read more on SWKS →